Celerion is a global leader in early clinical research services, committed to translational medicine. For over 50 years, Celerion has been providing comprehensive clinical trial solutions to pharmaceutical, biotechnology, and generic drug companies. With a strong focus on safety and scientific excellence, Celerion offers expertise in study design, clinical conduct across multiple therapeutic areas, advanced bioanalytical services, data management, biostatistics, and regulatory affairs to help accelerate the development of new medicines. Their facilities are equipped to conduct complex early-phase studies, including first-in-human, proof-of-concept, and patient population studies.
The Lincoln headquarters houses key corporate functions including executive leadership, global operations management, finance, human resources, IT, and strategic business development. It also features significant clinical research and bioanalytical laboratory capabilities.
The Lincoln facility includes state-of-the-art clinical pharmacology units designed for complex early-phase trials, extensive bioanalytical laboratories equipped with advanced instrumentation, and modern administrative office spaces.
The work culture at Celerion's headquarters emphasizes scientific rigor, collaboration, innovation, and a strong commitment to patient safety and data integrity. Employees are typically mission-driven, focusing on contributing to medical advancements.
Its central U.S. location provides good logistical access. The facility is a cornerstone of Celerion's global network, enabling comprehensive drug development services from a single, integrated site. It represents a significant investment in clinical research infrastructure.
Celerion supports global drug development programs through strategically located, state-of-the-art clinical research facilities and offices in North America (USA, Canada), Europe (UK, Switzerland), and Asia (South Korea). This international network enables comprehensive services including early and late-stage clinical trials, extensive bioanalytical capabilities, data management, biostatistics, and regulatory consulting. This global footprint allows Celerion to conduct multinational studies, access diverse patient populations, and navigate varied regulatory environments to support clients worldwide.
621 Rose Street
Lincoln
Nebraska
USA
Address: Innovation Centre, Queen's Road, Queen's Island, Belfast, BT3 9DT, UK
Serves as Celerion's primary clinical pharmacology unit in Europe, providing access to UK/EU patient populations and regulatory pathways. Facilitates early clinical development for biotech and pharma clients targeting European registration.
Address: 2420 W. Peoria Avenue, Phoenix, AZ 85029, USA
Complements the Lincoln headquarters by offering additional capacity and access to a diverse U.S. patient population for a wide range of early clinical studies and bioanalytical testing.
Address: Allmendstrasse 32, CH-8320 Fehraltorf, Zurich, Switzerland
Acts as the central European hub for advanced bioanalytical services, supporting preclinical and clinical development programs across Europe with specialized assay development, validation, and sample analysis.
Address: 4422 Joseph-Dubreuil, Lachine (Montreal), QC H8T 3C7, Canada
Provides North American clients with an alternative location for conducting early clinical trials, offering access to Canadian research infrastructure, patient populations, and potential R&D tax incentives.
Address: 10F, Signature Towers Seoul, 100 Cheonggyecheon-ro, Jung-gu, Seoul, 04542, Republic of Korea
Facilitates Celerion's clinical trial operations in Asia, supporting global studies by providing access to patient populations in South Korea and other APAC countries, and navigating regional regulatory landscapes.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Celerion' leadership includes:
Celerion has been backed by several prominent investors over the years, including:
Celerion has maintained a relatively stable executive team. One notable appointment strengthening its commercial leadership was Michelle Korte as Chief Commercial Officer in early 2023. No other major high-level executive departures or hires have been prominently announced in the immediate past 12-18 months.
Discover the tools Celerion uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Celerion primarily utilizes the email format combining an employee's first name and last name, separated by a period, followed by '@celerion.com'. Variations might exist but this is the most common structure.
firstname.lastname@celerion.com
Format
jane.doe@celerion.com
Example
90%
Success rate
Business Wire • March 27, 2024
Celerion announced its participation and presentation of eight scientific posters at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024 Annual Meeting in Colorado Springs, CO. The presentations covered various topics including abuse potential studies, advanced bioanalytical techniques, and innovative early-phase trial designs....more
Business Wire • January 10, 2023
Celerion announced the appointment of Michelle Korte as its new Chief Commercial Officer. Ms. Korte brings over 20 years of experience in the CRO and pharmaceutical industry to lead Celerion’s global commercial strategy....more
Celerion Website / Press Release • September 19, 2023
Celerion announced its scientific contributions at the 14th WRIB conference, with experts discussing advancements in bioanalytical methods and technologies critical for drug development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Celerion, are just a search away.